Skip to content
Global sound
Scrip Podcasts

Scrip Podcasts

Rethinking Risk: Why Early Evidence Strategy Matters for Emerging Biotechs

· 23 min

Show notes

For emerging biotech companies, development success is often measured by clinical milestones, safety, and efficacy. However, demonstrating an asset’s value extends beyond regulatory approval. Understanding patient needs and treatment experiences, as well as evolving stakeholder expectations, early in development plays an important role in shaping a more informed evidence strategy.

In this podcast, Ashwin Rai, Director of Data Science and Advanced Analytics, and Gale Harding, Senior Research Leader, from the PPD clinical research business of Thermo Fisher Scientific, discuss how integrating…

Live, last hour: 14,041 songs on 5,809 stations in 117 countries

Discover the world through radio

More ways to discover (7)

Heard something good? Save it, or open it straight away in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Nostalgie British 80Continue listening